Related Experiment Video

Updated: Sep 8, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Chemosensitization of solid tumor cells by alteration of their susceptibility to apoptosis

Ian A Cree1, Louise Knight, Federica Di Nicolantonio

  • 1Translational Oncology Research Centre, Department of Histopathology, Queen Alexandra Hospital, Cosham, Portsmouth, UK. ian.cree@port.ac.uk

Current Opinion in Investigational Drugs (London, England : 2000)
|July 2, 2002
PubMed

Insights

Chemosensitization enhances cancer therapy by making tumor cells more susceptible to drugs, often by altering drug metabolism or blocking resistance. Targeting apoptosis and using anti-angiogenic therapy alongside chemotherapy are promising future strategies.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • Chemosensitization involves using agents to increase cancer cell susceptibility to chemotherapy.
  • Mechanisms include enhanced drug metabolism, improved uptake, or overcoming resistance.
  • Targeting apoptosis and combining therapies are key areas of focus.

Purpose of the Study:

  • To review chemosensitization strategies in cancer therapy.
  • To highlight the potential of targeting apoptosis and combining anti-angiogenic therapy with chemotherapy.
  • To discuss the future importance of rational drug combination design.

Main Methods:

  • Review of current literature on chemosensitization strategies.
  • Analysis of mechanisms underlying chemosensitization.
  • Exploration of novel therapeutic combinations.

Main Results:

  • Chemosensitization can be achieved through various mechanisms, including modulating drug metabolism and resistance pathways.
  • Altering cancer cell susceptibility to apoptosis shows significant therapeutic promise.
  • Combining anti-angiogenic therapy with chemotherapy can enhance the therapeutic index.

Conclusions:

  • Chemosensitization strategies are crucial for improving cancer treatment efficacy.
  • Targeting apoptosis and integrating anti-angiogenic approaches represent key future directions.
  • Rational design of synergistic drug combinations is vital for early-stage drug development.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells09:12

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on: June 14, 2024

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...